Gene · 51428
Papers1,824
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,824
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Applicability of current prognostication models for MDS patients with DDX41 mutation. | Leuk Res | 2025 | 41072193 | PubTator, text mining | PubMed |
| Genomic variation in DDX41 identified through clinical sequencing. | Br J Haematol | 2025 | 41070677 | PubTator, text mining | PubMed |
| Germline predispositions to myeloid malignancies: Across the lifespan. | Semin Hematol | 2025 | 41046176 | PubTator, text mining | PubMed |
| Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers. | Eur J Hum Genet | 2025 | 41044237 | PubTator, text mining | PubMed |
| Factors affecting response and resistance to venetoclax in acute myeloid leukemia. | Front Oncol | 2025 | 41030943 | PubTator, text mining | PubMed |
| The BTK-DDX41 axis of the STING pathway is activated during cytomegalovirus lytic infection. | J Virol | 2025 | 40956132 | PubTator, text mining | PubMed |
| Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma. | Pigment Cell Melanoma Res | 2025 | 40956002 | PubTator, text mining | PubMed |
| Aggregation-Dependent Epitope Sequence and Modification Fingerprints of Anti-Aβ Antibodies. | bioRxiv | 2025 | 40950201 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies. | Blood Adv | 2025 | 40924929 | PubTator, text mining | PubMed |
| Glycosylphosphatidylinositol biosynthesis functions as a conserved host defense pathway against coronaviruses via regulation of LY6E. | PLoS Pathog | 2025 | 40901862 | PubTator, text mining | PubMed |
| DDX27 in cancer: molecular mechanisms, clinical implications, and therapeutic potential. | J Transl Med | 2025 | 40877927 | PubTator, text mining | PubMed |
| The CGG triplet repeat binding protein 1 counteracts R-loop induced transcription-replication stress. | EMBO Rep | 2025 | 40859011 | PubTator, text mining | PubMed |
| An invertebrate NLR recognizes viral nucleic acids and balances the antiviral signaling pathway through interaction with STING and Cyclophilin A. | PLoS Pathog | 2025 | 40825070 | PubTator, text mining | PubMed |
| Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms. | Blood Cancer J | 2025 | 40818987 | PubTator, text mining | PubMed |
| Novel Inhibitors of Plasmodium Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and In Vivo Efficacy in a Humanized Mouse Malaria Infection Model. | J Med Chem | 2025 | 40811478 | PubTator, text mining | PubMed |
| The Red Shift in Estrogen Research: An Estrogen-Receptor Targeted aza-BODIPY-Estradiol Fluorescent Conjugate. | Int J Mol Sci | 2025 | 40806208 | PubTator, text mining | PubMed |
| Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies. | Cell Death Discov | 2025 | 40804253 | PubTator, text mining | PubMed |
| CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription. | Nat Commun | 2025 | 40790042 | PubTator, text mining | PubMed |
| Identifying lncRNA-Protein Interactions in Hematopoietic Progenitor Cells by Hybridization Capture and Mass Spectrometry. | J Proteome Res | 2025 | 40747827 | PubTator, text mining | PubMed |
| Identification of Genetic Variants Using Next-Generation Sequencing in Pediatric Myelodysplastic Syndrome: From Disease Biology to Clinical Applications. | Int J Mol Sci | 2025 | 40725152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51428/papers?page=4